Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150433 · ClinicalTrials.gov registry record · NA
Sleep and Pain in Sickle Cell Disease
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT03150433: Completed NA study, sponsored by Johns Hopkins University.
NCT03150433 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03150433, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.
Interventions
- BEHAVIORAL Behavioral symptom management
- OTHER Sickle cell disease management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2017-11-05 |
| Est. Completion | 2023-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03150433
The ClinicalTrials.gov registry entry for NCT03150433 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral symptom management is the first listed.
NCT03150433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03150433 about?
NCT03150433 is a clinical study titled "Sleep and Pain in Sickle Cell Disease". This is a study testing the effects of behavioral sleep interventions on pain and brain function in sickle cell disease.
What is the current status of trial NCT03150433?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2017-11-05. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT03150433?
The interventions under investigation include: Behavioral symptom management (BEHAVIORAL), Sickle cell disease management (OTHER).
Who is sponsoring clinical trial NCT03150433?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.